Back
Trinity Biotech PLC Quote, Financials, Valuation and Earnings
Sponsored
TRIB
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
25
TRIB
Trinity Biotech PLC
Last Price:
1.59
Seasonality Move:
8.96%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeTrinity Biotech PLC Price Quote
$1.59
Trinity Biotech PLC Key Stats
Sell
25
Trinity Biotech PLC (TRIB)
is a Sell
Day range:
$1.56 - $1.68
52-week range:
$1.05 - $3.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.28
P/B ratio:
0%
Volume:
63.3K
Avg. volume:
185.3K
1-year change:
-24.77%
Market cap:
$15.1M
Revenue:
$56.8M
EPS:
$-2.7
How Much Does Trinity Biotech PLC Make?
-
How Much Are Trinity Biotech PLC's Sales Annually?
TRIB Revenues are $56.8M -
How Much Profit Does Trinity Biotech PLC's Make A Year?
TRIB net income is -$24M
Is Trinity Biotech PLC Growing As A Company?
-
What Is Trinity Biotech PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14% -
What Is Trinity Biotech PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Trinity Biotech PLC Stock Price Performance
-
Did Trinity Biotech PLC Stock Go Up Last Month?
Trinity Biotech PLC share price went down by -20.5% last month -
Did TRIB's Share Price Rise Over The Last Year?
TRIB share price fell by -24.77% over the past 1 year
What Is Trinity Biotech PLC 52-Week High & Low?
-
What Is Trinity Biotech PLC’s 52-Week High Share Price?
Trinity Biotech PLC has traded as high as $3.55 over the past 52 weeks -
What Is Trinity Biotech PLC’s 52-Week Low Share Price?
Trinity Biotech PLC has traded as low as $1.05 over the past 52 weeks
Trinity Biotech PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Trinity Biotech PLC?
-
How Much Debt Does Trinity Biotech PLC Have?
Total long term debt quarterly is $81M -
How Much Cash Does Trinity Biotech PLC Have?
Cash and short term investments quarterly total is $5.3M -
What Is Trinity Biotech PLC’s Book Value Per Share?
Book value per share is -3.11
Is Trinity Biotech PLC Cash Flow Positive?
-
What Is TRIB Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.3M -
What Is Trinity Biotech PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $18.6M -
What Is Trinity Biotech PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$18.9M
Trinity Biotech PLC Return On Invested Capital
-
Is Management Doing A Good Job?
TRIB return on invested capital is -52.33% -
What Is Trinity Biotech PLC Return On Assets?
ROA measures how assets are converting to revenues and is -29.36% -
What Is TRIB Return On Equity?
ROE is a measure of profitability and is 0%
Trinity Biotech PLC Earnings Date & Stock Price
-
What Is Trinity Biotech PLC's Stock Price Today?
A single share of TRIB can be purchased today for 1.59 -
What Is Trinity Biotech PLC’s Stock Symbol?
Trinity Biotech PLC trades on the nasdaq under the ticker symbol: TRIB -
When Is Trinity Biotech PLC’s Next Earnings Date?
The next quarterly earnings date for Trinity Biotech PLC is scheduled on January 31, 2025 -
When Is TRIB's next ex-dividend date?
Trinity Biotech PLC's next ex-dividend date is March 11, 2016 -
How To Buy Trinity Biotech PLC Stock?
You can buy Trinity Biotech PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Trinity Biotech PLC Competitors
-
Who Are Trinity Biotech PLC's Competitors?
Below is a list of companies who compete with Trinity Biotech PLC or are related in some way:
Trinity Biotech PLC Dividend Yield
-
What Is TRIB Dividend Yield?
Trinity Biotech PLC’s dividend yield currently is 0% -
What Is Trinity Biotech PLC’s Payout Ratio?
Trinity Biotech PLC’s payout ratio is 0% -
When Did Trinity Biotech PLC Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Trinity Biotech PLC’s Dividend Per Share?
Trinity Biotech PLC pays a dividend of $0.00 per share
Trinity Biotech PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 14% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 15.00 |
Upside from Last Price: | 843.4% |